The molecular aspects of chordoma
- 12 September 2015
- journal article
- review article
- Published by Springer Science and Business Media LLC in Neurosurgical Review
- Vol. 39 (2), 185-196
- https://doi.org/10.1007/s10143-015-0663-x
Abstract
Chordomas are one of the rarest bone tumors, and they originate from remnants of embryonic notochord along the spine, more frequently at the skull base and sacrum. Although they are relatively slow growing and low grade, chordomas are highly recurrent, aggressive, locally invasive, and prone to metastasize to the lungs, bone, and the liver. Chordomas highly and generally show a dual epithelial-mesenchymal differentiation. These tumors resist chemotherapy and radiotherapy; therefore, radical surgery and high-dose radiation are the most used treatments, although there is no standard way to treat the disease. The molecular biology process behind the initiation and progression of a chordoma needs to be revealed for a better understanding of the disease and to develop more effective therapies. Efforts to discover the mysteries of these molecular aspects have delineated several molecular and genetic alterations in this tumor. Here, we review and describe the emerging insights into the molecular landscape of chordomas.Keywords
This publication has 111 references indexed in Scilit:
- Chordoma Characterization of Significant Changes of the DNA Methylation PatternPLOS ONE, 2013
- The T-box transcription factor Brachyury regulates epithelial–mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cellsBMC Cancer, 2012
- Aldehyde Dehydrogenase 1, a Potential Marker for Cancer Stem Cells in Human SarcomaPLOS ONE, 2012
- Recurrent Chromosomal Copy Number Alterations in Sporadic ChordomasPLOS ONE, 2011
- Endogenous Wnt/β-Catenin Signaling Is Required for Cardiac Differentiation in Human Embryonic Stem CellsPLOS ONE, 2010
- T (brachyury) gene duplication confers major susceptibility to familial chordomaNature Genetics, 2009
- Chordoma and chondrosarcoma gene profile: implications for immunotherapyCancer Immunology, Immunotherapy, 2008
- Mouse ES cell–derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genesJCI Insight, 2008
- Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisationBritish Journal of Cancer, 2007
- Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patientBritish Journal of Cancer, 2007